Browse by category

A study conducted at Harvard University has identified the central role of serotonin - a hormone involved in mood regulation - in the...

There has been a marked decline in the number of patients seeking private bariatric and metabolic surgery (BMS) in the UK, from 5,900 in...

BioAge Labs is to discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag as monotherapy and in...

Zealand Pharma has enrolled the first participant has been enrolled in ZUPREME-1, a global Phase 2b trial in people with obesity or...

Bariatric News  talked to Dr Jassim Fakhro, Senior Consultant in General, Metabolic, Bariatric and Robotic Surgery, Vice President of the...

Eli Lilly and Company has announced topline results from the SURMOUNT-5 phase 3b open-label randomised clinical trial that found Zepbound...

Amylyx Pharmaceuticals plans to initiate a Phase 3 LUCIDITY clinical trial for avexitide, an investigational, first-in-class...

Massachusetts Institute of Technology (MIT) engineers have designed a new type of gastric balloon that can be inflated and deflated as...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

The Smart Panther Automatic Stapler (Panther Healthcare) is safe and effective with very low rates of bleeding and zero complications in...